ANDHealth ACTIVATE
AcceleratorMelbourne · Pre-Seed–Series A · 19 people tracked
Find your way into ANDHealth ACTIVATE
Sign up to see every warm intro you have to ANDHealth ACTIVATE
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ANDHealth ACTIVATE team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
ANDHealth operates a non-profit, cooperative commercialisation model designed to identify, assess and accelerate digital and connected health startups across Australia, supporting founders and CEOs from idea through to global market uptake. Its flagship program, ANDHealth+ (AH+), helps translate and commercialise proof-of-concept digital health technologies through clinical trials, commercial pilots, investment and implementation, ultimately delivering new products to patients. The organisation facilitates industry investment and support for high-growth companies and provides intermediary services. AH+ cohort and alumni companies have collectively raised significant investment, generated new revenue, run clinical trials, and created jobs, with roughly 90% of alumni now generating revenue.
Source: firm website, verified Sep 26, 2026.
Team · 19 people
from the firm's website & curatedFounder of ANDHealth (2017) with over 20 years of executive experience in health technology commercialisation, venture capital and capital raising. She serves on the Council of the NHMRC and is a Non-Executive Director of Lumos Diagnostics (ASX:LDX).
Commercialisation professional and fund program leader who runs delivery of the $33M+ MRFF-funded ANDHealth+ program and co-manages the CUREator+ programs, overseeing cohort selection, due diligence and portfolio strategy. Holds an MBA from the University of Sydney.
Health and medical research commercialisation leader with over 30 years' experience, formerly at NSW Health where she designed and governed programs including the NSW Medical Devices Fund. She was awarded the Public Service Medal in 2025 and sits on the LifeSciences Australia board.
Communications and marketing director who has led ANDHealth's digital reach since 2021, with over a decade of experience in strategic communications, social media, digital campaigns and design.
Investor, adviser and entrepreneur in innovation and commercialisation, former inaugural CEO of the Office of Innovation and Science Australia and co-founder of the Melbourne Accelerator Program.
Finance and governance professional with over 25 years' experience across listed, private and not-for-profit companies, providing company secretarial and CFO services in digital health, life sciences and biotech. Chartered Accountant and Fellow of the Governance Institute of Australia.
Non-Executive Chair of ANDHealth with a 40-year career in medical technology across Australia/NZ and Asia, formerly Managing Director ANZ and VP Asia Pacific for Johnson & Johnson Medical Devices, and a director of several companies and not-for-profits.
Medtech commercialisation leader with over eight years scaling early-stage ventures, co-founder and former COO of Seer Medical, and a mentor to pre-revenue startups on commercial strategy and investment readiness.
Events and stakeholder engagement professional with over 15 years in life sciences, previously at AusBiotech working on investment attraction, now supporting ANDHealth's CHICC programs.
Director of CHICC and National Events with over seven years in healthtech, previously Events and Projects Manager at BioMelbourne Network and a former resource geologist.
Healthcare information sector executive with over 25 years' experience and Group Managing Director of ASX-listed Alcidion, bringing perspective on later-stage capital markets.
Communications professional with over 20 years' experience in strategic and crisis communications across government and corporate sectors, previously a Managing Director at Teneo in Dubai and adviser to prime ministers in Australia and New Zealand.
Biomedical engineer, data analyst and tech founder with experience in medical technology and clinical research, skilled in Python, data analysis and pipeline development.
Chief of Staff supporting the CEO on strategic initiatives, with over 5 years in digital and connected health commercialisation. As former Portfolio Manager and Lead Analyst he helped deploy over $8M across five portfolio companies in the ANDHealth+ and CUREator+ non-dilutive programs.
Finance and corporate services leader with over 35 years' experience across chartered accounting, government and not-for-profit boards, most recently leading VicHealth's organisational transformation.
Experienced chair and non-executive director across biotech and health technology, chair of Neurizon Therapeutics and a former 23-year Deloitte Australia partner with expertise in governance, capital markets and R&D commercialisation.
Program Director leading LaunchVic-funded initiatives supporting 15 early-stage digital health startups annually, with over five years of program management experience and a Health Sciences background.
Innovation professional focused on the convergence of technology, life science and health, with experience building health ventures across Australia and Sweden spanning AI diagnostics, regenerative medicine and medical devices.
Anya Roy is co-founder of Syrona Health. She previously worked in venture capital and genomics roles at Goldman Sachs and Illumina, and holds a degree in Bioscience from Cambridge University.
Founder mafia
2 people who came through ANDHealth ACTIVATE went on to found or lead other companies.
What they invest in
from 2 of 3 portfolio companiesDigital Health ×2Healthtech ×2AI & Machine Learning ×1B2B Marketplaces ×1Enterprise Software ×1Fintech ×1SaaS ×1
HQs:United States×2
Portfolio companies · 3 tracked
alumni founders can tell you what the program is really likeBy year:2025 · 12024 · 12021 · 13 dated
MDisrupt is an AI-powered marketplace that connects healthtech, life sciences, and medical device innovators with vetted clinical, scientific, regulatory, and commercial experts.
AI & Machine LearningB2B MarketplacesDigital HealthEnterprise SoftwareFintechHealthtechSaaS
Ruby Gadelrab(Founder & CEO)inGreg Nagy(Chief Operating Officer)inRoger Davies(Chief Technology Officer)in
Co-investors37 AngelsBDev VenturesGeek VenturesGrowth Factory VenturesMindshift CapitalStone Mountain Ventures+3 more
Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke.
Digital HealthHealthtechNew York, US
Sameer Madan(Founder)inElizabeth Burstein(Founder)in
Co-investorsCorrelation VenturesE12 Venture Capital, LlcEsplanade VenturesKoch Disruptive TechnologiesMitsui Global InvestmentNext Play Ventures+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- What stage does ANDHealth ACTIVATE invest at?
- ANDHealth ACTIVATE invests at the Pre-Seed, Seed, Series A stages.
- What sectors does ANDHealth ACTIVATE focus on?
- ANDHealth ACTIVATE focuses on Digital Health, Healthtech, Medical Devices.
- Where is ANDHealth ACTIVATE located?
- ANDHealth ACTIVATE is headquartered in Melbourne, AU.
Media · Podcasts & interviews
from their channel🚀 Supercharge your startup with ANDHealth ACTIVATE
ANDHealth
The remarkable impact of ANDHealth+
ANDHealth
Hear how ACTIVATE, supported by LaunchVic, helped Virtetic take the company to the next level
ANDHealth
Hear how ACTIVATE, supported by LaunchVic, helped SmartHeal take the company to the next level
ANDHealth
Hear how ACTIVATE, supported by LaunchVic, helped Humanetix take the company to the next level
ANDHealth
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Future Positive Capital is a venture firm that backs entrepreneurs building companies aimed at solving universal challenges at planetary scale across science and technology.
Investinor AS is a Norwegian state-backed investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.






































